メインコンテンツにスキップ
検索

Radnor, PA – 2025年6月20日 – Certara, Inc. バイオシミュレーションのグローバルリーダーであるサターラ(Nasdaq:CERT) はCERT), a global leader in model-informed drug development, today announced the release of Integral™ version 25.4.1, the latest update to its secure cloud-based platform for document management and e-signature workflows. This release introduces significant upgrades to the REST API, enabling customers to build integrated, efficient, and scalable pharmacokinetic (PK) data workflows.

とコンプライアンス
Visualize
Analyze
Exploratory
Capture
専門家に相談する

Designed to meet the evolving needs of regulatory, clinical, and IT teams, Integral 25.4.1 helps life sciences organizations streamline operations, automate routine tasks, and more easily connect Integral with other systems and processes including Phoenix, Certara’s pharmacokinetic/pharmacodynamic analysis and modeling platform. “This release gives our customers more power and flexibility to automate their work and integrate Integral into their broader digital ecosystem,” said Martin Snyder, President, Certara Data Sciences. “It reflects our continued investment in making the platform smarter, faster, and easier to manage.”

Key Highlights of Integral 25.4.1:

  • REST API Enhancements: A broader range of API endpoints for flexibility in managing folders and files from outside the application, accelerating integration with other data sources.
  • Single Sign-On and Centralized Administration: Unified access management through Certara Admin across all Certara products.
  • Streamlined eSignature Workflow: Faster, plugin-free signing experience that aligns with Certara’s modern authentication framework.
  • Expanded Logging and Audit Trails: Increased transparency into user sessions and administrative actions, supporting 21 CFR Part 11 compliance and security goals.

These updates are part of Certara’s broader vision to provide a seamless and scalable platform that evolves alongside customer needs in drug development and regulatory environments. The Integral release coincides with the release of Phoenix 8.6.

To learn more about Integral and the latest enhancements, visit https://www.certara.com/integral-data-repository/

Certara(サターラ)について

サターラは、モデリング&シミュレーション・ソフトウェアと技術を用いて、従来の創薬・開発を変革し、医薬品をよりスピーディーに患者さんに届けることをミッションとしています。製薬、教育機関、規制当局のお客様 2,400人以上、70ヵ国にてサターラの技術やサービスが活用されています。Learn more at certara.com.

サターラの問い合わせ先

Sheila Rocchio
[email protected]

報道機関の皆様:

赤津笑美 (emi.akatsu@certara.com)
[email protected]

Increase the efficiency of your PK analysis from repository to report

In this webinar, Jocelyn Webb, Associate Director of Global Pharmacokinetics at Charles River Laboratories, shared how her team built a workflow designed for efficiency and consistency, highlighting the roles of Integral and other features of the Phoenix Platform.

ウェビナーを視聴する
Powered by Translations.com GlobalLink Web Software